Company intelligence / Profile preview

Beijing Hongfan Biotechnology

Ownership: Private
Development stage: Other

Overview

Beijing Hongfan Biotechnology specializes in high-quality nucleic acid raw materials and contract development/manufacturing services. The company supports customers from early research through commercial production, with world-leading capacity in phosphoramidites and nucleotide triphosphates. It does not develop its own therapeutics but enables RNA medicine innovation by supplying critical components with exceptional quality standards.

Modalities: OligonucleotidesmRNA-based drugsNucleic acid raw materials
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Beijing Hongfan Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Hongfan Biotechnology.

Explore the full profile